Categories: All postsHardware

Avigilon still has nearly 40% upside, Haywood says

It has been a strong performer this year, but ahead of the company’s third quarter results, Haywood Securities analyst Pardeep Sangha thinks there is still plenty of money to be made on Avigilon (Avigilon Stock Quote, Chart, News: TSX:AVO).

Today, after market close, Avigilon will report its Q3, 2017 results. Sangha thinks the company will generate Adjusted EBITDA of $20.3-million on revenue of $114.3-million, numbers that are better than the street consensus of EBITDA of $18.5-million on revenue of $107.8-million. The analyst says he will be looking at a number of developments in the quarter.

“On the conference call, we will be listening for: Update on annual guidance. Our annual forecast of 18% revenue growth and 16% Adj. EBITDA margins are within the Company’s guidance for CY17 revenue between $390M and $425M (10% to 20% growth), with Adj. EBITDA margins between 13% and 17%; Details and timing of the sale of its office tower building for $107.5M, which was originally purchased for $42M; Pipeline and growth prospects for the second half of the year; Increasing sales in the Company’s new higher margin products; Update on monetizing the IP and licensing division,” Sangha says.

In a research update to clients Monday, Sangha maintained his “Buy” rating and one-year price target of $25.50 on Avigilon, implying a return of 38.9 per cent at the time of publication.

Sangha thinks Avigilon will generate Adjusted EBITDA of $68.2-million on revenue of $416.7-million in fiscal 2017. He thinks those numbers will improve to EBITDA of $88.9-million on a topline of $477.0-million the following year.

Avigilon’s share price has increased 43% this year. Avigilon is currently trading at 10.8x EV/EBITDA of our CY17 estimates, which is below the peer group average of 16.1x EV/EBITDA of CY17 consensus estimates,” the analyst explains. “Our target price represents a 9.9x EV/EBITDA multiple of our CY18 Adj. EBITDA.”

Tagged with: avo
Nick Waddell

Cantech Letter founder and editor Nick Waddell has lived in five Canadian provinces and is proud of his country's often overlooked contributions to the world of science and technology. Waddell takes a regular shift on the Canadian media circuit, making appearances on CTV, CBC and BNN, and contributing to publications such as Canadian Business and Business Insider.

Recent Posts

Tilray: why this analyst just cut his price target

Haywood Securities analyst Neal Gilmer says lower Canadian cannabis market share is weighing on Tilray Brands (Tilray Brands Stock Quote,… [Read More]

16 hours ago

Why National Bank likes Anaergia right now

National Bank Financial analyst Baltej Sidhu says Anaergia’s (Anaergia Stock Quote, Chart, News, Analysts, Financials TSX:ANRG) divestiture of two legacy… [Read More]

16 hours ago

Canada’s provinces are leading investment boom, RBC says

RBC assistant chief economist Cynthia Leach says the public sector is playing a larger role in Canada’s investment boom than… [Read More]

16 hours ago

Can Eupraxia Pharmaceuticals stock go even higher?

Research Capital analyst Andre Uddin says Eupraxia Pharmaceuticals (Eupraxia Pharmaceuticals Stock Quote, Chart, News, Analysts, Financials TSX:EPRX) reported another strong… [Read More]

16 hours ago

Is it time to buy VersaBank stock?

Roth Capital Partners analyst Craig Irwin says VersaBank (VersaBank Stock Quote, Chart, News, Analysts, Financials NASDAQ:VBNK) is nearing a potential… [Read More]

16 hours ago

Rapid Micro Biosystems has a 240% upside, this analyst says

Roth Capital Partners analyst Max Masucci says Rapid Micro Biosystems (Rapid Micro Biosystems Stock Quote, Chart, News, Analysts, Financials NASDAQ:RPID)… [Read More]

17 hours ago